News

Keep you updated

with the latest info of XtalPi

hit discovery
XtalPi Joins Forces with Microsoft China to Pioneer AI-Driven Breakthroughs in Life Sciences and Beyond
XtalPi Licenses XtalFold™ AI Platform to Janssen Biotech for Next-Gen Biologics Discovery
About XtalPi, a pioneering AI drug discovery company
MIT and XtalPi Forge Partnership to Pioneer AI-Driven Scientific Discovery
Dr. Wen Shuhao Appointed to MIT Visiting Committee, Becoming Youngest Member in Chemistry Division
hit discovery
XtalPi’s AI Platform Validated as Partner Companies Secure IND Approvals and Major Funding
XtalPi Debuts on HKEX Main Board as First 18C Listing, Pioneering AI + Robotics Innovation
XtalGazer | Advanced Solid State Research for Drug Discovery
XtalPi Launches XtalGazer™: Revolutionizing Drug Crystallization with AI-Driven Precision
Dr. Ma Jian Meets Hong Kong Chief Executive John Lee, Signs MoU with Hetao Shenzhen-Hong Kong Innovation Cooperation Zone
Singapore Deputy Prime Minister Heng Swee Keat Visits XtalPi, Commends AI-Driven Innovations
XtalPi Chairman Highlights AI as Foundational Infrastructure at Fortune Innovation Forum
XtalPi Announces Collaboration with Lilly, Using AI + Robotics to Uncover First-in-class Therapeutics
XtalPi Announces Research Collaboration with Janssen

Search XtalPi

Unlock Faster, Smarter Polymorph Screening with XtalGazer™ CSP
Unlock Faster, More Accurate Drug Discovery with XFEP
Templated Nucleation of Clotrimazole and Ketoprofen on Polymer Substrates

XtalPi Newsletter